F2G is currently owned by Sofinnova Partners, through Sofinnova Crossover Fund I, since 2019.

When did Sofinnova Partners acquire F2G?

Sofinnova Partners acquired F2G in 2019 (active for 7 years).

Home/Companies/Biotech/F2G

F2G

Biotech·

UK·Active·7yr hold

F2G is a healthcare / biotech company, headquartered in United Kingdom.

Entry

2019

Hold

7yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQUnited Kingdom

SectorHealthcare / Biotech

UK clinical-stage company focused on developing olorofim and other novel antifungal therapies for life-threatening invasive fungal…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Crossover Fund I

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings